Please ensure Javascript is enabled for purposes of website accessibility
Home > Products > Antibodies > Biosimilars

Research Grade Visugromab (HV986026)

Research Grade Visugromab
Research Grade Visugromab
Price(USD): $
Spec:
  • 100ug
  • 1mg
Number:
Contact us
  • Overview

  • Images

  • References

  • Datasheet

Overview
Catalog No.HV986026
Description
Visugromab (HV986026) is a research-grade recombinant antibody targeting PLAB. Produced in mammalian cells with native-like glycosylation.
Highlights
  • Research Grade — For PK/PD studies, assay development, and ADA research.
  • Native Glycosylation — Mammalian expression ensures native-like patterns.
Species reactivityHuman
ApplicationsELISA, Bioactivity: FACS, Functional assay, Research in vivo
Host speciesHumanized
IsotypeIgG4-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target PLAB, Placental bone morphogenetic protein, MIC1, NRG-1, PTGFB, NSAID-regulated gene 1 protein, GDF15, NAG-1, MIC-1, Prostate differentiation factor, NSAID-activated gene 1 protein, Growth/differentiation factor 15, Macrophage inhibitory cytokine 1, Placental TGF-beta, GDF-15, PDF
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G purified from cell culture supernatant.
Accession Q99988
Form Liquid
Storage buffer 0.01M PBS, pH 7.4.

Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.

Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate NamesCTL002, CTL-002, CTL002, 2556646-63-8
Background

Growth/differentiation factor 15 (GDF15/MIC1) is a ~34 kDa protein. Hormone produced in response to various stresses to confer information about those stresses to the brain, and trigger an aversive response, characterized by nausea, vomiting, and/or loss of appetite. The aversive response is both required to reduce continuing exposure to those stresses at the time of exposure and to promote avoidance behavior in the future. Acts by binding to its receptor, GFRAL, activating GFRAL-expressing neurons localized in the area postrema and nucleus tractus solitarius of the brainstem. It then triggers the activation of neurons localized within the parabrachial nucleus and central amygdala, which constitutes part of the 'emergency circuit' that shapes responses to stressful conditions. The GDF15-GFRAL signal induces expression of genes involved in metabolism, such as lipid metabolism in adipose tissues.

1. Tsai, VW. et al. (2013) PloS one 8, e55174. PMID: 23468844
2. Tsai, VW. et al. (2014) PloS one 9, e100370. PMID: 24971956
3. Mullican, SE. et al. (2017) Nature medicine 23, 1150-1157. PMID: 28846097
4. Emmerson, PJ. et al. (2017) Nature medicine 23, 1215-1219. PMID: 28846098
5. Yang, L. et al. (2017) Nature medicine 23, 1158-1166. PMID: 28846099
6. Hsu, JY. et al. (2017) Nature 550, 255-259. PMID: 28953886
7. Xiong, Y. et al. (2017) Science translational medicine 9. PMID: 29046435
8. Patel, S. et al. (2019) Cell metabolism 29, 707-718.e8. PMID: 30639358
9. Coll, AP. et al. (2020) Nature 578, 444-448. PMID: 31875646
10. Klein, AB. et al. (2021) Nature communications 12, 1041. PMID: 33589633
Note For research use only. Not suitable for clinical or therapeutic use.
Images
  • Research Grade Visugromab

    SDS-PAGE

    SDS-PAGE for Research Grade Visugromab

References
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recommendation

Contact us for custom quotes, bulk requests and any other issues.

Mail: support@abinScience.com

Distributor list